Hepatic veno-occlusive disease (HVOD) is a serious life-threatening complication of
hematopoietic stem cell transplantation (HSCT). Currently, there is no optimal therapeutic …

Hepatic veno‐occlusive disease (VOD) is a common transplant‐related complication of stem
cell transplantation. There is no safe and proven therapy for established VOD, and attempts …

We report the long-term results of a prospective randomized study on the use of
ursodeoxycholic acid (UDCA) for prevention of hepatic complications after allogeneic stem …

Background Hepatic veno‐occlusive disease (VOD) is a severe complication after
haematopoietic stem cell transplantation (HSCT). Different drugs with different mechanisms …

The role of ursodeoxycholic acid (UDCA) in the prevention of hepatic complications after
allogeneic stem cell transplantation was studied in a prospective randomized open-label …

Hepatic veno-occlusive disease is a clinical syndrome characterized by hepatomegaly,
ascites, weight gain and jaundice, due to sinusoidal congestion which can be caused by …

Hepatic veno-occlusive disease (VOD) is a common and serious regimen-related toxicity
after hematopoietic stem cell transplantation (HSCT). There is no safe and proven therapy …

We evaluated 40 patients undergoing high-dose chemo/radiotherapy (HDCT) and
hematopoietic stem cell transplantation (HSCT)(allogeneic (22), autologous (18)) to …

Hepatic veno-occlusive disease (VOD) is one of the most common and important regimen-
related toxicities observed after hematopoietic stem cell transplantation (HSCT). There are …

Hepatic veno-occlusive disease is a serious regimen-related toxicity in patients undergoing
hematopoietic stem cell transplantation. We performed a systematic review and meta …